Michael Anstey

Partner at Cambridge Innovation Capital Ltd

Michael Anstey

Michael Anstey

Partner at Cambridge Innovation Capital Ltd

Overview
Career Highlights

Proteorex Therapeutics, Inc.

RelSci Relationships

2242

Number of Boards

6

Birthday

1981

Age

39

Contact Data
Trying to get in touch with Michael Anstey? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Michael Anstey likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Bicycle Therapeutics Plc

Relationship likelihood: Strong

Managing Partner at Cambridge Innovation Capital Ltd

Relationship likelihood: Strong

Chief Executive Officer & Director at Bicycle Therapeutics Plc

Relationship likelihood: Strong

President at Taiho Ventures LLC

Relationship likelihood: Strong

Executive Chairman at Cambridge Innovation Capital Ltd

Relationship likelihood: Strong

Co-Founder at Axol Bioscience Ltd.

Relationship likelihood: Strong

Partner & Chief Financial Officer at Cambridge Innovation Capital Ltd

Relationship likelihood: Strong

Co-Founder at Amadeus Capital Partners Ltd.

Relationship likelihood: Strong

Partner at Cambridge Innovation Capital Ltd

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Adapsyn Bioscience, Inc.

Relationship likelihood: Strong

Paths to Michael Anstey
Potential Connections via
Relationship Science
You
Michael Anstey
Partner at Cambridge Innovation Capital Ltd
Education
Dphil
Class of 2007

Oxford is a collegiate university, consisting of the central University and colleges. The central University is composed of academic departments and research centres, administrative departments, libraries and museums. The 38 colleges are self-governing and financially independent institutions, which are related to the central University in a federal system. There are also six permanent private halls, which were founded by different Christian denominations and which still retain their Christian character.

Queen's University at Kingston (commonly shortened to Queen's University or Queen's) is a public research university located in Kingston, Ontario, Canada. Founded on 16 October 1841, the university predated the founding of Canada by 26 years. Queen's holds more than 1,400 hectares (3,500 acres) of land throughout Ontario and owns Herstmonceux Castle in East Sussex, England. Queen's is organized into ten undergraduate, graduate and professional faculties and schools. The Church of Scotland established Queen's College in 1841 with a royal charter from Queen Victoria. The first classes, intended to prepare students for the ministry, were held 7 March 1842 with 13 students and two professors. Queen's was the first university west of the maritime provinces to admit women, and to form a student government. In 1883, a women's college for medical education affiliated with Queen's University. In 1888, Queen's University began offering extension courses, becoming the first Canadian university to do so. In 1912, Queen's secularized and changed to its present legal name.

Memberships
Fellow
Current

The Society of Kauffman Fellows is a network of venture capitalists operating at 160 venture firms and corporate venture groups in 26 countries on 6 continents, collectively deploying $50B in venture capital.

Career History
Partner
2017 - Current

Cambridge Innovation Capital Ltd is an active investment manager invests seed and early stage transactions in companies located in the United Kingdom. The firm in which sectors they invest include life sciences and technology companies, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital heath and genomics/proteomics.

Co-Founder & Chief Operating Officer
2014 - 2018

Proteorex Therapeutics, Inc. develops novel therapeutics. It is discovering small-molecule drugs to treat diseases with the greatest unmet medical need. The firm’s drug discovery platform integrates a novel synthesis design strategy, machine learning, and patient-derived cell-based screening to unlock targets considered undruggable using existing approaches. The company was founded by Aman Iqbal, Kong T. Nguyen, Robert Batey and Michael Anstey and is headquartered in Toronto, Canada.

Principal-Healthcare Practice Area
2010 - 2017

The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.

Boards & Committees
Director
Current

Buckman Laboratories SARL wholesales chemicals to the paint industry. The firm markets its products under the brand names such as BUCKMAN, BUFLOC, BULAB, BUSAN, BUSPERSE, and BUTROL. The company was founded on December 21, 2007 and is headquartered in Wasquehal, France.

Investments
Details Hidden

Proteorex Therapeutics, Inc. develops novel therapeutics. It is discovering small-molecule drugs to treat diseases with the greatest unmet medical need. The firm’s drug discovery platform integrates a novel synthesis design strategy, machine learning, and patient-derived cell-based screening to unlock targets considered undruggable using existing approaches. The company was founded by Aman Iqbal, Kong T. Nguyen, Robert Batey and Michael Anstey and is headquartered in Toronto, Canada.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michael Anstey. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michael Anstey's profile does not indicate a business or promotional relationship of any kind between RelSci and Michael Anstey.